American Oriental Bioengineering Independent research, analysis and opininons on American Oriental Bioengineering.
| Company: |
American Oriental Bioengineering,
Inc. |
| Ticker: |
AOB |
| Profile Price: |
$4.98 September 15, 2005 |
| Sold Price |
$5.25 November 23, 2005 |
| Gain (loss) |
+5% |
| Valuation: |
$312 million |
| Website: |
http://www.bioaobo.com |
| Disclosure: |
This recommendation was made
prior to formation of Stock Aware, LLC |
| Original Hot Points of
Research and Analysis: |
•
Chinese biotechnology company
with over 800 employees and more than one hundred products.
The products range from herbal-based pharmaceuticals, health
supplements and a soybean peptide series.
• The herbal-based
pharmaceuticals include a prescription remedy for chronic
bedwetting and nighttime urination, a medicine that is used
for regulating the blood sugar balance for people with
diabetic symptoms and a medicine that is used for immune
system disorder.
•
Recent growth in revenues and earnings per share leads us to
believe the stock is undervalued.
Regular updates are only available through
our Free Stock Newsletter
|
